Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

MLA

D:A:D Study Group, et al. Use of Nucleoside Reverse Transcriptase Inhibitors and Risk of Myocardial Infarction in HIV-Infected Patients Enrolled in the D:A:D Study: A Multi-Cohort Collaboration. Jan. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3662..075b02d2a50b796f7a693ecff9ce2444&authtype=sso&custid=ns315887.

APA

D:A:D Study Group, Sabin, C., Worm, S., Weber, R., Reiss, P., El Sadr, W., Dabis, F., De Wit, S., Law, M., D’Arminio Monforte, A., Friis Møller, N., Kirk, O., Pradier, C., Weller, I., Phillips, A., Collaborators, C. S. L. J. D., El Sadr WM, Phillips, A., Rosseau, F., … Yerly, S. (2008). Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

Chicago

D:A:D Study Group, Ca Sabin, Sw Worm, R Weber, P Reiss, W El Sadr, F Dabis, et al. 2008. “Use of Nucleoside Reverse Transcriptase Inhibitors and Risk of Myocardial Infarction in HIV-Infected Patients Enrolled in the D:A:D Study: A Multi-Cohort Collaboration,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3662..075b02d2a50b796f7a693ecff9ce2444&authtype=sso&custid=ns315887.